Thyrotoxicosis incidence in Switzerland and benefit of improved iodine supply

Lancet

Volumn 352, Issue 9133, 1998, Pages 1034-

  Burgi H ^a   Kohler, M ^b   Morselli, B ^b  

^a Bürgerspital   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IODINE;

ARTICLE; GRAVES DISEASE; HUMAN; IODINE DEFICIENCY; PRIORITY JOURNAL; SWITZERLAND; THYROTOXICOSIS; URINARY EXCRETION;

EID: 0032569460     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60076-1     Document Type: Article

References (5)

1. 1 Clugston G, Beaudry M, Delange F. Iodine-induced thyrotoxicosis. Lancet 1996; 347: 1051.
2. 2 Todd CH, Allain T, Gomo ZAR, Hasler JA, Ndiweni M, Oken E. Increase in thyrotoxicosis associated with iodine supplements in Zimbabwe. Lancet 1995; 346: 1563-64.
3. 3 Bourdoux PP, Ermans AM, Mukalay wa Mukalay A, Filetti S, Vigerni R. Iodine-induced thyrotoxicosis in Kivu, Zaire. Lancet 1996; 347: 552-53.
4. 4 Baltisberger BL, Minder ChE, Bürgi H. Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 1995; 132: 546-49.
5. 5 Corvilain B, van Sande J, Dumont JE, Bourdoux P, Ermans AM. Autonomy in endemic goiter. Thyroid 1998; 8: 107-13.